The global clinical nutrition for diabetes care market size was valued at USD 2.4 billion in 2025 and is projected to grow from USD 2.5 billion in 2026 to USD 3.5 billion by 2033, growing at a CAGR of 4.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 34.0% in 2025. The increasing demand for specialized food products by individuals with diabetes or those at risk of developing the condition is a critical factor for the diabetes clinical nutrition market growth. This includes people with type 1 or type 2 diabetes, as well as those following a diabetic diet.
The rising prevalence of diabetes, driven by aging, obesity, sedentary lifestyles, and unhealthy dietary habits, is a major factor supporting the growth of the global clinical nutrition market. According to the International Diabetes Federation (IDF), approximately 589 million adults aged 20-79 years were living with diabetes worldwide in 2024, representing around 11.1% of the global adult population. This figure is projected to reach 853 million by 2050, reflecting the increasing global burden of the disease. Diabetes remains a leading cause of serious complications, including cardiovascular disease, chronic kidney disease, blindness, and lower-limb amputations, with risks increasing due to aging, obesity, physical inactivity, poor dietary habits, and inadequate glycemic control.
As the prevalence of diabetes and its associated complications continues to rise, healthcare providers are increasingly incorporating specialized clinical nutrition interventions to support glycemic control, improve nutritional status, and enhance long-term patient outcomes. Disease-specific medical foods, oral nutritional supplements, and enteral and parenteral nutrition play an important role in managing nutritional deficiencies and slowing disease progression in high-risk patients. Furthermore, a study by the University of Minnesota reported a 62% increase in the incidence of type 2 diabetes in the U.S. following the COVID-19 pandemic, particularly among children and adolescents aged 10-19 years, highlighting the growing need for effective nutritional management.
Growing consumer awareness, supportive public health initiatives, and increasing scientific evidence regarding the benefits of nutrition in diabetes management are further driving demand for diabetes-specific nutrition products. Consumers are increasingly seeking low-sugar, low-carbohydrate, and nutritionally balanced products that offer convenience without compromising taste, while many are willing to pay a premium for healthier alternatives. This shift in consumer preferences is expected to support sustained growth in the diabetes clinical nutrition market.
▪ Canada
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
▪ China
▪ India
▪ Australia
▪ Thailand
▪ South Korea
▪ Mexico
▪ Argentina
▪ Saudi Arabia
▪ UAE
▪ Kuwait
The rising prevalence of diabetes, driven by aging, obesity, sedentary lifestyles, and unhealthy dietary habits, is a major factor supporting the growth of the global clinical nutrition market. According to the International Diabetes Federation (IDF), approximately 589 million adults aged 20-79 years were living with diabetes worldwide in 2024, representing around 11.1% of the global adult population. This figure is projected to reach 853 million by 2050, reflecting the increasing global burden of the disease. Diabetes remains a leading cause of serious complications, including cardiovascular disease, chronic kidney disease, blindness, and lower-limb amputations, with risks increasing due to aging, obesity, physical inactivity, poor dietary habits, and inadequate glycemic control.
As the prevalence of diabetes and its associated complications continues to rise, healthcare providers are increasingly incorporating specialized clinical nutrition interventions to support glycemic control, improve nutritional status, and enhance long-term patient outcomes. Disease-specific medical foods, oral nutritional supplements, and enteral and parenteral nutrition play an important role in managing nutritional deficiencies and slowing disease progression in high-risk patients. Furthermore, a study by the University of Minnesota reported a 62% increase in the incidence of type 2 diabetes in the U.S. following the COVID-19 pandemic, particularly among children and adolescents aged 10-19 years, highlighting the growing need for effective nutritional management.
Growing consumer awareness, supportive public health initiatives, and increasing scientific evidence regarding the benefits of nutrition in diabetes management are further driving demand for diabetes-specific nutrition products. Consumers are increasingly seeking low-sugar, low-carbohydrate, and nutritionally balanced products that offer convenience without compromising taste, while many are willing to pay a premium for healthier alternatives. This shift in consumer preferences is expected to support sustained growth in the diabetes clinical nutrition market.
Global Clinical Nutrition for Diabetes Care Market Report Segmentation
This report forecasts revenue growth at the global, country, and regional levels, and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global clinical nutrition for diabetes care market report based on product, stage, sales channel, and region:Product Outlook (Revenue, USD Million, 2021 - 2033)
- Oral Nutrition
- Parenteral Nutrition
- Enteral Feeding Formulas
Stage Outlook (Revenue, USD Million, 2021 - 2033)
- Adult
- Pediatric
Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Online
- Retail
- Institutional Sales
Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
▪ Canada
- Europe
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
- Asia Pacific
▪ China
▪ India
▪ Australia
▪ Thailand
▪ South Korea
- Latin America
▪ Mexico
▪ Argentina
- Middle East and Africa (MEA)
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Global Clinical Nutrition for Diabetes Care Market Variables, Trends & Scope
Chapter 4. Global Clinical Nutrition for Diabetes Care Market: Product Estimates & Trend Analysis
Chapter 5. Clinical Nutrition for Diabetes Care Market: Stage Estimates & Trend Analysis
Chapter 6. Global Clinical Nutrition for Diabetes Care Market: Sales Channel Estimates & Trend Analysis
Chapter 7. Global Clinical Nutrition for Diabetes Care Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Abbott Nutrition
- Pfizer Inc.
- Bayer AG
- Nestle Health Science S.A.
- GlaxoSmithKline plc
- Baxter International Inc.
- Otsuka Holdings Co., Ltd.
- Mead Johnson & Company, LLC
- Danone Nutricia
- Victus, Inc.
